Use of Pre- and Intensified Postprocedural Physiotherapy in Patients with Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement Study (the 4P-TAVR Study)
Table 3
Outcome measures.
All patients (n = 108)
Training group (n = 58)
Control group (n = 50)
value
90-day mortality (n (%))
11 (10.2)
6 (10.3)
5 (10.0)
0.62
90-day rehospitalization (n (%))
28 (25.9)
16 (27.6)
12 (24.0)
0.30
90-day mortality or rehospitalization (n (%))
35 (32.4)
20 (34.5)
15 (30.0)
0.44
Hospital duration (days)
11.62 ± 7.19
10.1 ± 4.7
13.5 ± 6.1
0.023
Duration of intensive care therapy (days)
3.2 ± 1.9
3.1 ± 1.7
3.4 ± 2.2
0.34
PPC score
0.87 ± 1.04
0.74 ± 1.00
1.02 ± 1.07
0.21
PPC score >2 (n (%))
14 (12.9)
4 (6.9)
10 (20.0)
0.028
Pneumonia (n (%))
13 (12.0)
3 (5.1)
10 (20.0)
0.016
30-day MACCE (n (%))
5 (4.6)
2 (3.5)
3 (6)
0.406
30-day mortality (n (%))
4 (3.7)
2 (3.5)
2 (4)
0.556
30-day myocardial infarction (n (%))
0 (0)
0 (0)
0 (0)
—
30-day major vascular complications (n (%))
4 (3.7)
2 (3.5)
2 (4)
0.633
30-day stroke rate (n (%))
1 (0.9)
0 (0)
1 (2)
0.463
PPC, postoperative pulmonary complication; MACCE, major adverse cardiac and cerebrovascular events.
